Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02797093 · ClinicalTrials.gov registry record
Impact of ART Adherence on HIV Persistence and Inflammation
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 71
- Enrollment target
NCT02797093: Completed study, sponsored by University of Colorado, Denver.
NCT02797093 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02797093 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the relationship between anti-retroviral therapy (ART) adherence with levels of human immunodeficiency virus (HIV) reservoir and residual viremia in suppressed, HIV-infected individuals on chronic ART.
Primary Outcome
Evaluation of variations in ART cumulative adherence are associated with the size of the HIV reservoir and with the degree of chronic inflammation and immune activation in HIV-infected, virologically suppressed individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-10-12 |
What the finished NCT02797093 record still lists
NCT02797093 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02797093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02797093 about?
NCT02797093 is a clinical study titled "Impact of ART Adherence on HIV Persistence and Inflammation". The purpose of this study is to evaluate the relationship between anti-retroviral therapy (ART) adherence with levels of human immunodeficiency virus (HIV) reservoir and residual viremia in suppressed, HIV-infected individuals on chronic ART.
What is the current status of trial NCT02797093?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2016-01. Estimated completion is 2018-10-12.
Who is sponsoring clinical trial NCT02797093?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia